米国の脊椎手術市場の評価：製品別、手術別、適応疾患別、手技別、エンドユーザー別、地域別、機会、予測、2017年～2031年

米国の脊椎手術の市場規模は、予測期間の2024年～2031年のCAGRが4.19％となり、2023年の48億6,000万米ドルから2031年には68億米ドルに成長すると予測されています。同市場の成長を支えているのは、背中や脊椎の損傷、椎間板変性症、脊椎感染症、椎間板痛の症例の増加、市場の主な参入企業による新技術開発に向けた投資の増加、低侵襲手術への嗜好の高まりです。

Christopher &Dana Reeve Foundationの推計によると、毎年約18,000件の脊髄損傷症例が新たに報告されています。脊髄損傷の結果、脊椎を圧迫する可能性のある異物、骨片、椎骨骨折、椎間板ヘルニアを除去するために外科手術が必要となることが多いため、この増加が米国の脊椎手術市場の需要を促進しています。

国内で肥満の脅威が高まっていることも、市場の拡大を支える大きな要因です。国立糖尿病・消化器・腎臓病研究所の推計によると、米国では成人の3人に1人近くが太り過ぎです。この増加は、過度の体重が衝撃吸収椎間板の挟み込みやヘルニアを引き起こし、外科的処置の必要性につながるため、市場の需要を後押ししています。

技術の進歩は、医療提供者が手術の精度を向上させることで患者の予後を改善し、回復時間を短縮する革新的なソリューションを提供することが期待されるため、米国における脊椎手術の需要を促進しています。また、主な市場参入企業は、患者の利便性を向上させ、慢性腰痛を管理する機器の開発にも注力しています。2024年4月、Medtronic Plcは、閉ループ式・充電式脊髄刺激装置Inceptivの米国食品医薬品局（FDA）認可を取得しました。インセプティブ脊髄刺激装置は、生体信号を感知することで、患者の要求に合わせた所定の刺激を維持します。このような発展は市場の拡大を支援し、有利な成長の機会をもたらすと期待されています。

当レポートでは、米国の脊椎手術市場について調査し、市場の概要とともに、製品別、手術別、適応疾患別、手技別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 米国の脊椎手術市場の見通し、2017年～2031年

• 市場規模の分析と予測
• 市場シェア分析と予測
• 市場マップ分析、2023年
  • 製品別
  • 手術別
  • 適応疾患別
  • 手技別
  • エンドユーザー別
  • 地域別

第5章 需要供給分析

第6章 輸出入の分析

第7章 バリューチェーン分析

第8章 ポーターのファイブフォース分析

第9章 PESTLE分析

第10章 価格分析

第11章 市場力学

第12章 市場の動向と発展

第13章 規制枠組みとイノベーション

第14章 特許の情勢

第15章 ケーススタディ

第16章 競合情勢

• 市場リーダー上位5社の競合マトリックス
• 上位5社のSWOT分析
• 主要企業上位10社の情勢
  • Abbott Laboratories
  • Stryker Corporation
  • Medtronic Plc.
  • Boston Scientific Corporation
  • Johnson & Johnson Services Inc. (DePuy Synthes)
  • Globus Medical, Inc.
  • B. Braun Melsungen AG
  • ZimVie Inc.
  • Alphatec Holdings, Inc.
  • Orthofix Medical Inc.

第17章 戦略的提言

第18章 お問い合わせと免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Spine Surgery Market, By Value, In USD Billion, 2017-2031F
• Figure 2. United States Spine Surgery Market, By Volume, In Units, 2017-2031F
• Figure 3. United States Spine Surgery Market Share (%), By Products, 2017-2031F
• Figure 4. United States Spine Surgery Market Share (%), By Surgery, 2017-2031F
• Figure 5. United States Spine Surgery Market Share (%), By Disease Indication, 2017-2031F
• Figure 6. United States Spine Surgery Market Share (%), By Procedure, 2017-2031F
• Figure 7. United States Spine Surgery Market Share (%), By End-user, 2017-2031F
• Figure 8. United States Spine Surgery Market Share (%), By Region, 2017-2031F
• Figure 9. By Products Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 10. By Surgery Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 11. By Disease Indication Size Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 12. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 13. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 14. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

United States spine surgery market is projected to witness a CAGR of 4.19% during the forecast period 2024-2031, growing from USD 4.86 billion in 2023 to USD 6.80 billion in 2031. The growth of the market is supported by the rising cases of back and spine injury, degenerative disc disease, spinal infections, and disc pain, rising investments by the key players of the market towards the development of novel technologies, and growing preference for minimally invasive surgeries.

According to the estimates of the Christopher & Dana Reeve Foundation, approximately 18,000 new cases of spinal cord injury are reported every year. This increase is propelling the United States spine surgery market demand as surgical procedures are often necessary for removing foreign objects, fragments of bones, and fractured vertebrae and herniated discs that may compress the spine as a result of spinal cord injuries.

The growing threat of obesity in the country is another major factor supporting the expansion of the market. According to the estimates of the National Institute of Diabetes and Digestive and Kidney Diseases, nearly 1 in 3 adults in the United States are overweight. This rise bolsters the market demand as excessive weight can cause the shock-absorbing discs to become pinched or herniated, resulting in the requirement for surgical procedures.

Technological Advancements Support Market Expansion

Technological advancements are propelling the demand for spine surgeries in the United States as they are expected to offer innovative solutions that allow healthcare providers to enhance patient outcomes and decrease recovery time by improving surgical precision. The key market players are also focusing on developing devices to improve patient convenience and manage chronic back pain. In April 2024, Medtronic Plc received approval from the US Food and Drug Administration (FDA) for their closed-loop and rechargeable spinal cord stimulator, Inceptiv. The inceptive spinal cord stimulators maintain the prescribed stimulation tailored to the patient's requirements by sensing biological signals. Such developments are expected to support market expansion and provide lucrative growth opportunities.

Increasing Cases of Spinal Cord Injury Bolster Market Demand

The rising cases of spinal cord injuries in the United States are expected to provide lucrative growth opportunities to the market. As per the estimates of the Christopher & Dana Reeve Foundation, approximately 302,000 individuals are living with spinal cord injury in the United States. This increase is propelling the requirement for spine surgeries in the countries as they are required to keep the bones in the proper position while they are undergoing healing. The results of spinal cord injuries often vary depending upon the location and type of the injury and can result in slowing of autonomic nerve function and loss of sensory and motor functions, among others.

Growing Preference for Minimally Invasive Procedures Boosts the Market

The growing preference for minimally invasive spine surgeries among patients can be attributed to their increasing awareness about the various advantages offered by them including less pain after the procedure due to limited tissue and muscle damage, decreased loss of blood, and reduced risk of infection. Due to the rising number of minimally invasive spine surgery procedures, the key players of the market are actively investing towards the development of devices that enhance the convenience of the surgeons and ensure the smooth completion of the surgery. In April 2023, Orthofix Medical Inc. announced the launch of two access retractor systems for minimally invasive spine procedures. The Fathom Pedicle-Based Retractor System and Lattus Lateral Access System expanded Orthofix's offerings of access solutions for addressing the various requirements associated with minimally invasive procedures. The Lattus system addresses the important areas of lateral spine surgery, including plate fixation, removal or preparation of the disc, interbody placement, and easy access to the spine.

Spinal Fusion Devices Hold Significant Share of the Market

The spinal fusion device helps heal fusions and provides additional spine stability. They also aid in correcting malalignment, enhancing spinal fusion, and improving the overall stability of the spine by restricting movement in the treated spinal segment, securing bone graft material, and serving as a medium to replace the spinal disc. Due to the rising requirement for spinal fusion devices, the key players of the market are increasingly focusing on new product launches, further aiding the growth of the segment. In November 2023, in the United States, Orthofix Medical Inc. commercially launched their WaveFormL system, which is intended for lateral lumbar interbody fusion procedures.

Future Market Scenario (2024-2031F)

As per the United States spine surgery market analysis, the market demand is expected to increase significantly in the coming years due to rising obesity in the country and increasing investments by the key market players towards the introduction of new devices and systems. Boston Scientific Corporation is conducting an interventional study for compiling the real-world outcomes of the Superion Indirect Decompression System (IDS) in routine clinical trials, when the directions of use are followed. The study is expected to conclude in June 2029. Additionally, the growing awareness about spine health and the availability of different devices for managing and treating various conditions is also expected to support the market's expansion in the United States.

Key Players Landscape and Outlook

The growth of the United States spine surgery market is supported by the increasing investments by the key players of the market towards the introduction of novel products and technologies in the country. In January 2024, Abbott Laboratories announced that their Liberta RC deep brain stimulation (DBS) system was approved by the United States Food and Drug Administration (U.S. FDA). The system features NeuroSphere Virtual Clinic, which supports the programming of the system remotely. The Liberta RC DBS system is a first-of-its-kind technology that allows patients in the United States to receive new treatment settings and communicate with their doctors remotely. The company developed the system after research showcases that Abbott DBS users in the United States travel over 150 miles, on average, to meet with a movement disorder specialist. Such introductions and approvals are expected to enhance consumer convenience and aid companies in expanding their customer base in the country.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. United States Spine Surgery Market Outlook, 2017-2031F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Products
    • 4.2.1.1. Spinal Fusion Devices
    • 4.2.1.2. Spinal Decompression Devices
    • 4.2.1.3. Non-Fusion Devices
    • 4.2.1.4. Others
  • 4.2.2. By Surgery
    • 4.2.2.1. Open Surgery
    • 4.2.2.2. Minimally Invasive Surgery
  • 4.2.3. By Disease Indication
    • 4.2.3.1. Degenerative Disc Disease
    • 4.2.3.2. Complex Deformity
    • 4.2.3.3. Traumas and Fractures
    • 4.2.3.4. Others
  • 4.2.4. By Procedure
    • 4.2.4.1. Discectomy
    • 4.2.4.2. Laminotomy
    • 4.2.4.3. Foraminotomy
    • 4.2.4.4. Corpectomy
    • 4.2.4.5. Facetectomy
  • 4.2.5. By End-user
    • 4.2.5.1. Hospitals
    • 4.2.5.2. Ambulatory Surgical Centers
    • 4.2.5.3. Specialty Clinics
    • 4.2.5.4. Others
  • 4.2.6. By Region
    • 4.2.6.1. Northeast
    • 4.2.6.2. Southwest
    • 4.2.6.3. West
    • 4.2.6.4. Midwest
    • 4.2.6.5. Southeast
  • 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
• 4.3. Market Map Analysis, 2023
  • 4.3.1. By Products
  • 4.3.2. By Surgery
  • 4.3.3. By Disease Indication
  • 4.3.4. By Procedure
  • 4.3.5. By End-user
  • 4.3.6. By Region

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Clinical Trials
• 13.2. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players
  • 16.3.1. Abbott Laboratories
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
  • 16.3.2. Stryker Corporation
  • 16.3.3. Medtronic Plc.
  • 16.3.4. Boston Scientific Corporation
  • 16.3.5. Johnson & Johnson Services Inc. (DePuy Synthes)
  • 16.3.6. Globus Medical, Inc.
  • 16.3.7. B. Braun Melsungen AG
  • 16.3.8. ZimVie Inc.
  • 16.3.9. Alphatec Holdings, Inc.
  • 16.3.10. Orthofix Medical Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer